Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fabricio Colacino Silva"'
Autor:
Paulo D'Amora, Ismael Dale C G Silva, Maria Auxiliadora Budib, Ricardo Ayache, Rafaela Moraes Siufi Silva, Fabricio Colacino Silva, Robson Mateus Appel, Saturnino Sarat Júnior, Henrique Budib Dorsa Pontes, Ana Carolina Alvarenga, Emilli Carvalho Arima, Wellington Galhano Martins, Nakal Laurenço F Silva, Ricardo Sobhie Diaz, Marcia B Salzgeber, Anton M Palma, Steven S Evans, Robert A Nagourney
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0259909 (2021)
This study investigated the association between COVID-19 infection and host metabolic signatures as prognostic markers for disease severity and mortality. We enrolled 82 patients with RT-PCR confirmed COVID-19 infection who were classified as mild, m
Externí odkaz:
https://doaj.org/article/2d6f9073a84446dca68372ebde0279bf
Autor:
Robert A. Nagourney, Maria Auxiliadora Budib, Nakal Laurenço F. Silva, Ricardo Sobhie Diaz, Emilli Carvalho Arima, Fabricio Colacino Silva, Anton M. Palma, Marcia Batista Salzgeber, Rafaela Moraes Siufi Silva, Wellington Galhano Martins, Robson Mateus Appel, Ricardo Ayache, Saturnino Sarat Júnior, Paulo D'Amora, Ismael Dale C. G. Silva, Ana Carolina Alvarenga, Steven S. Evans, Henrique Budib Dorsa Pontes
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 12, p e0259909 (2021)
PLoS ONE, Vol 16, Iss 12, p e0259909 (2021)
This study investigated the association between COVID-19 infection and host metabolic signatures as prognostic markers for disease severity and mortality. We enrolled 82 patients with RT-PCR confirmed COVID-19 infection who were classified as mild, m
Autor:
Edison Fedrizzi, Fabricio Colacino Silva, Ana Maria Massad Costa, Sylvia Michelina Fernandes Brenna, Cristina Valletta de Carvalho, Ismael Guerreiro da Silva, Flavio Zucchi
Publikováno v:
Journal of Cancer Therapy. :434-445
The human papillomavirus (HPV) is the etiologic agent of genital cancer, but alone it is incapable of inducing oncogenesis. Rather, progression to invasive lesions is associated with host immunity and interference in the process of cellular apoptosis
Autor:
Luciana Rodrigues Gomes, João S Neto, Ismael Dale Cotrim Guerreiro da Silva, Mari Cleide Sogayar, Fabricio Colacino Silva, Rita C S Figueira
Publikováno v:
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
BMC Cancer, Vol 9, Iss 1, p 20 (2009)
BMC Cancer
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
BMC Cancer, Vol 9, Iss 1, p 20 (2009)
BMC Cancer
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Financiadora de Estudos e Projetos (FINEP) Pro-Reitoria da Universidade de São Paulo (PRP-USP) Background: the m
Autor:
Fabricio Colacino Silva, Nise Hitomi Yamaguchi, Gilberto Lopes, Paulo D'Amora, Robert A. Nagourney, André Nebel de Mello, Rene Claudio Gansl, Fernando C. Maluf, Antonio C. Buzaid
Publikováno v:
Journal of Clinical Oncology. 33:e17782-e17782
e17782 Background: Precision medicine offers improved response rates (RR) & cost containment. Pancreatic cancer (PC) with Stage IV 5-yr survival of 1-2% is ideal for strategies that pre-select resp...
Autor:
Nise Hitomi Yamaguchi, Paula J. Bernard, Fernando C. Maluf, Fabricio Colacino Silva, Robert A. Nagourney, Paulo D'Amora, Steven S. Evans, Antonio C. Buzaid, Federico R. Francisco
Publikováno v:
Journal of Clinical Oncology. 31:e13562-e13562
e13562 Background: Personalized oncology has advanced through genomic and proteomic platforms. BCR-abl; EGFr and ALK have provided drug-able targets and companion diagnostics in several diseases, yet many transforming events in humans are polygenic,
Autor:
Ismael Dcg Silva, Fabricio Colacino Silva, Suma I. Shimuta, Afonso Celso Pinto Nazário, Adriana C. Mesquita, Samuel Marcos Ribeiro de Noronha, Silvana Aa Correa-Noronha, Juvenal J. Linhares
Publikováno v:
Cancer Research. 72:2598-2598
Background: Many different types of cancer (renal, lung, colorectal, prostate, uterus, breast and pancreatic) have already been associated to polymorphisms of the Renin Angiotensin System (RAS) genes. Angiotensin II (Ang II) is a vasoconstrictor, a m
Autor:
Suma I. Shimuta, Murilo Vieira Geraldo, Fabricio Colacino Silva, Edna Teruko Kimura, Clovis R. Nakaie, Cristina V. Carvalho, Ismael Dale Cotrim Guerreiro da Silva, Samuel Marcos Ribeiro de Noronha, José Juvenal Linhares, Adalberto Abraao Siufi, Ana Maria Massad Costa, Silvana Aparecida Alves Correa-Noronha
Publikováno v:
Cancer Research. 71:5592-5592
Background: Angiotensin II (AngII) exerts promitotic, pro-proliferative and angiogenic effects and the administration of angiotensin I-converting enzyme (ACE) inhibitors reduces tumor growth in animal models of cancer. AngII type 1 receptor (AGTR1) i